C - Chemistry – Metallurgy – 12 – P
Patent
C - Chemistry, Metallurgy
12
P
167/139, 167/37,
C12P 21/08 (2006.01) C07K 14/47 (2006.01) C07K 16/30 (2006.01) G01N 33/53 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2013544
The present invention discloses a method of determining the prognosis of a cancer patient by determining the presence or absence of Retinoblastoma gene product in tumor antibodies which specifically bind to the hydrophilic c-terminus of the retinoblastoma protein are also provided.
Fung Yuen Kai
T'ang Anne
Borden Ladner Gervais Llp
Canji Inc.
LandOfFree
Retinoblastoma gene product antibodies and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retinoblastoma gene product antibodies and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retinoblastoma gene product antibodies and uses therefor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1538966